Skip to main content
メニュー
JP

Resource Center

Filters
Select resource types (1)
Select products & services
Select solutions (1)
Active Filters (2)
Clear All
1 - 12 of 33 Results
Sort by: Best Match
Best Match
Title A-Z
Title Z-A
Filter & Sort
Publication Icon   Literature - Publication Review
Expert interview: recapitulating the blood-brain barrier using in vitro hiPSC models in drug discovery
Better understand the blood-brain barrier for translational research and drug discovery in neurodegenerative diseases.
Publication Icon   Literature - Publication Review
The impact of pan-KRAS inhibitors on cancer drug discovery
Read how Boehringer Ingelheim generated compounds to target the "undruggable" KRAS pathway with the help of Revvity's preclinical services.
Publication Icon   Literature - Publication Review
SVEP1 as a regulator of GPCR-mediated vasoconstriction
This literature review describes how scientists uncovered multifunctional roles of SVEP1, a known contributor to cardiovascular disease.
Publication Icon   Literature - Publication Review
Spleen-targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
Researchers used the IVIS Spectrum and IVISbrite D-luciferin substrate to investigate how a spleen-targeted DNA vaccine, delivered via RBC-hitchhiked nanoparticles, effectively induced robust neoantigen specific T cell responses in HCC.
Publication Icon   Literature - Publication Review
Ultrasound imaging provides noninvasive 3D views into vascular changes in response to cancer therapy
Ultrasound imaging using the Vega® automated system provides noninvasive 3D views into vascular changes in response to cancer therapy.
Publication Icon   Literature - Publication Review
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Dr. Kawaoka Yoshihiro, a world-renowned virologist uses the Quantum microCT system to study SARS-CoV-2 in Syrian hamster models.
Publication Icon   Literature - Publication Review
Evaluating a novel nanoparticle platform for controlled liraglutide release in a Type II diabetes mouse model
Optical imaging using the IVIS® Platform to evaluate a novel nanoparticle system for controlled liraglutide release in a diabetic mouse model.
Publication Icon   Literature - Publication Review
Improving engineered T cell efficacy for treating solid tumors through epigenetic modulation
Researchers used the Opera Phenix® HCS and IVIS® preclicinal imaging system to evaluate engineered T-cells through epigenetic modulation showing the potential of improving the cytotoxic effects on solid tumors.
Publication Icon   Literature - Publication Review
In vivo imaging of influenza virus infection in immunized mice
Using the IVIS® in vivo imaging platform to quantifiy H1N1pmd09-Nluc influenza viral load in mice and demonstrated that human mAb administration has a protective or therapeutic effect in mice challenged with influenza virus.
Publication Icon   Literature - Publication Review
Biopolymers Codelivering Engineered T Cells and STING Agonists can Eliminate Heterogenous Tumors
Using the IVIS® Spectrum non-invasive preclinical optical system to quantify tumor-specific T cells responses in NFAT-luciferase transgenic mice.
Publication Icon   Literature - Publication Review
Establishing a baseline and drug-induced SMN expression profile in SMA disease-relevant human tissues in expedited autopsies
Research in establishing SMN expression level baselines in disease-relevant human tissues across.
Publication Icon   Literature - Publication Review
Tumor-targeting nanoparticles for enhanced PROTAC delivery
This publication review highlights how researchers using the IVIS Lumina III optical imaging system and Cellometer cell counter to study the potential of tumor-targeting nanoparticles to significantly enhance PROTAC delivery.
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.